Abstract
Tissue-resident memory T cells (TRM) protect from repeated infections within organs and barrier sites. The breadth and duration of such protection is defined at minimum by three quantities; the rate at which new TRM are generated from precursors, their rate of self-renewal, and their loss rate through death, egress, or differentiation. Quantifying these processes in isolation is challenging. Here we combine genetic fate mapping tools and mathematical models to untangle these basic homeostatic properties of CD4+ TRM in skin and lamina propria (LP) of healthy adult mice. We show that CD69+CD4+ TRM in skin reside for ∼ 24 days and self-renew more slowly, such that clones halve in size approximately every 5 weeks; and approximately 2% of cells are replaced daily from precursors. CD69+CD4+ TRM in LP have shorter residencies (∼ 14 days) and are maintained largely by immigration (4-6% per day). We also find evidence that the constitutive replacement of CD69+CD4+ TRM at both sites derives from circulating effector-memory CD4+ T cells, in skin possibly via a CD69− intermediate. Our integrated approach maps the ontogeny of CD4+ TRM in skin and LP and exposes their dynamic and distinct behaviours, with continual seeding and erosion potentially impacting the duration of immunity at these sites.
Introduction
Resident memory T cells (TRM) provide immune surveillance and protection in tissues and mucosal surfaces through-out the body (Szabo et al., 2019), but the mechanisms by which they are maintained are not well understood. Conventional CD4+ and CD8+ TRM in mice and humans are not intrinsically long-lived, but appear to self-renew slowly as assessed by readouts of cell division such Ki67 expression or BrdU incorporation, at levels that vary across tissues (Gebhardt et al., 2009, Watanabe et al., 2015, Park et al., 2018, Strobl et al., 2020, Divito et al., 2020, Christo et al., 2021). After infection or immune challenge, the numbers of elicited TRM may also be sustained by influx from precursor populations, although the extent to which this occurs is unclear, and is likely also cell subset- and tissue-dependent. For example, in the lung there is evidence both for (Zammit et al., 2006, Ely et al., 2006, Slütter et al., 2017, Van Braeckel-Budimir et al., 2018, Takamura and Kohlmeier, 2019) and against (Takamura et al., 2016, van Dorp et al., 2024) ongoing recruitment of new TRM following respiratory virus infections. Within skin, TRM may be renewed or supplemented slowly from precursors in the setting of graft-versus-host disease (Divito et al., 2020), and from circulating central memory TCM or effector memory TEM following infection or sensitisation (Gaide et al., 2015, Matos et al., 2022). In the small intestine, however, resident CD4+ and CD8+ TRM appear to persist for months to years with slow self-renewal without appreciable influx (Bartolomé-Casado et al., 2019, 2021).
The dynamics of production and loss of TRM in the steady state are even less well understood, and measuring these processes is important for several reasons. The balance of loss and self-renewal defines the persistence of clonal populations and hence the duration of protective immunity. Further, while self-renewal can at best preserve clonal diversity within a tissue site, any supplementation or replacement by immigrant TRM will perturb the local TCR repertoire. In particular, any significant influx into TRM niches in the absence of overt infection may be a competitive force, potentially reducing the persistence TRM previously established in response to infection or challenge.
The kinetics of circulating memory T cells have been quantified extensively in both mice and humans, using dye dilution assays (Choo et al., 2010), deuterium labelling (Westera et al., 2013, 2015, del Amo et al., 2018, Baliu-Piqué et al., 2018, 2019, van den Berg et al., 2021), and BrdU labelling, either alone (Younes et al., 2011, Ganusov and De Boer, 2013) or in combination with fate reporters (Gossel et al., 2017, Hogan et al., 2019, Bullock et al., 2024) or T cell receptor excision circles (den Braber et al., 2012). Using mathematical models to interpret these data, these studies identified rates of production, cellular lifespans, and signatures of heterogeneity in turnover. Modelling has also established evidence for continuous replenishment of circulating memory CD4+ T cells from precursors throughout life in specific-pathogen-free mice, driven by a combination of environmental, commensal and self antigens (Gossel et al., 2017, Hogan et al., 2019, Bullock et al., 2024). Quantification of TRM dynamics has to date been restricted largely to measuring the net persistence of CD8+ TRM following infection in mice, in a variety of tissues (Morris et al., 2019, Wijeyesinghe et al., 2021). Far less is known regarding CD4+ TRM, which typically outnumber their CD8+ counterparts (Szabo et al., 2019), and there have been very few attempts to dissect the kinetics of either subset (van Dorp et al., 2024).
In general, measuring these basic parameters in isolation is challenging, partly due to their sensitivity to assumptions made in the models (De Boer and Perelson, 2013), but also because division-linked labelling alone may not distinguish in situ cell division and the supplementation of a population from labelled precursors. A more powerful approach is to triangulate information from different readouts of cell fate simultaneously (Bains et al., 2009, den Braber et al., 2012, del Amo et al., 2018, De Boer and Yates, 2023, Bullock et al., 2024).
With these challenges in mind, here we integrated data from two independent inducible fate reporter systems to study CD4+ TRM homeostasis in mice. Each system allows one to track the fates of defined populations of cells and their descendants. One labels all CD4+ T cell subsets at any given moment, which effectively provides an age ‘timestamp’. The other labels cells undergoing cell division within defined time windows. In combination, these systems allowed us to establish a quantitative model of the basal homeostatic properties of CD4+ TRM within the skin and the lamina propria of the small intestine in healthy mice. In particular, we could unpick the contributions of self renewal and de novo cell production that underpin their maintenance, and explore their lineage relationships to circulating T cell subsets.
Results
Combining cell fate reporters and models to measure TRM replacement, loss, and self-renewal
To study the homeostatic dynamics of tissue resident CD4+ memory T cells in healthy mice, we used in concert two genetic fate mapping tools in which cohorts of peripheral T cells and their offspring can be induced to express permanent fluorescent markers (Fig. 1A). These reporter strains were previously used separately to study the turnover of naive and circulating memory T and B cells (Verheijen et al., 2020, Lukas et al., 2023, Bullock et al., 2024). In the Ki67mCherry-CreERT Rosa26RcagYFP system, henceforth Ki67-DIVN, fluorescent reporters are linked to the expression of Ki67, a nuclear protein that is expressed during cell division and for 3 to 4 days afterwards (Gossel et al., 2017, Miller et al., 2018). Specifically, these mice express both a Ki67-mCherry fusion protein and inducible CreERT from the Mki67 locus, together with a Rosa26RcagYFP Cre reporter construct. Treatment of mice with tamoxifen therefore induces YFP in cells expressing high levels of Ki67, and YFP is then stably expressed by these cells and their offspring. Expression of Ki67-used mCherry gives a constitutive live readout of Ki67 expression, independent of tamoxifen treatment and YFP expression. In the second fate reporter, CD4CreERT Rosa26RmTom mice (Cd4-FR), the Cre reporter is constructed such that cells expressing CD4 during tamoxifen treatment permanently and heritably express the fluorescent reporter mTomato (mTom).

Overview of the fate-reporter approach to quantifying the homeostasis of skin- and LP-resident CD4+ T cells.
A Ki67 and CD4 reporter constructs. B Schematic of a simple mathematical model of TRM homeostasis at steady state. New cells enter a TRM subset in skin or LP (the ‘target’ population) from a precursor population at rate θ (cells per unit time). YFP and mTom expression among immigrant cells is assumed to be that of the precursor population in bulk. We considered three possibilities for the Ki67 expression levels among new immigrants; a ‘quiescent’ mode (all Ki67low), ‘neutral’ recruitment (Ki67high frequency identical to that of the precursor). or ‘division-linked’ (all recruited cells Ki67high). The target cells are assumed to be a kinetically homogeneous population that self-renews at average rate ρ, such that their mean interdivision time is 1/ρ. Cells are also lost through death, differentiation or tissue egress at rate δ, implying a mean residence time of 1/δ. The combination of these processes determines the timecourses of frequencies of YFP+ and mTom+ cells with the target population. C Experimental design.
In a closed population of cells at steady state, self-renewal must be balanced by loss and so, following tamoxifen treatment, the frequencies of cells expressing YFP or mTom within any such population would remain constant. Therefore, any decline in the frequency of either reporter among TRM after treatment must derive from the influx of label-negative cells from an upstream (precursor) population. In the Ki67-DIVN mice, these will be descendants of cells that were not dividing at the time of tamoxifen treatment; in the Cd4-FR mice, labelled CD4+ cells will slowly be replaced by the descendants of those generated in the thymus after treatment. The shape of this decline will be determined by the combination of the net loss rate of TRM from the tissue (through death, egress, or differentiation, offset by any self-renewal), and the label content of immigrant TRM (Fig. 1B). To refer to the persistence of individual TRM cells we will use the term ‘residence time’ rather than lifespan, to reflect the multiple potential mechanisms of loss from tissues.
To quantify these processes, we treated cohorts of both reporter mice, aged between 4 and 15 weeks, with single 2mg pulses of tamoxifen (Fig. 1C). Over 9 week (Ki67 reporter) and 57 week (CD4 reporter) chase periods we measured the frequencies of labelled cells among antigen-experienced CD4+ T cell subsets isolated from skin and the lamina propria of the small intestine (henceforth LP), and within circulating naive and memory T cell subsets derived from lymph nodes (Fig. S1A). By combining these frequencies with measures of Ki67 expression, and describing the resulting set of time series with simple mathematical models, we aimed to estimate the basic parameters underlying TRM kinetics.
CD4+ TRM in skin and lamina propria are continuously replaced from precursors
We considered two populations within both skin and LP, identified as tissue-localised by virtue of their protection from short-term in vivo labelling (Methods; Fig. S1B). One was effector-memory (EM) phenotype (CD4+CD44hi CD62Llo) T cells in bulk, which we studied in order to gain the broadest possible picture of memory cell dynamics at these sites. We also considered the subset of these cells that expressed CD69, a canonical and consistent marker of CD4+ T cell residency across multiple tissues (Szabo et al., 2019). We saw no significant changes with mouse age in the numbers of either population within skin (Fig. 2A, p >0.67) or LP (Fig. 2B, p > 0.39). There were also no significant changes in any of these quantities with time since tamoxifen treatment (p > 0.24). We therefore assumed that the skin- and LP-localised T cell subsets we considered were at, or close to, homeostatic equilibrium during the chase period. For brevity, we refer to tissue-localised CD4+CD44hiCD62Llo in bulk as EM, and the CD69+ subset as TRM.

Modelling fate reporter dynamics among CD4+ T cell subsets in skin and lamina propria.
A,B Numbers of CD4+ effector-memory (EM) phenotype and CD4+CD69+T cells recovered from (A) ear skin, and (B) lamina propria in the small intestine, against mouse age. P-values are derived from Spearman rank correlation on data from the Cd4-FR and Ki67-DIVN strains combined. C Observed (points) and best-fit model trajectories (black lines) of the frequencies of mTom+ and YFP+ CD4+ T cell subsets within skin and LP, and the proportions of YFP+ and YFP− cells that expressed Ki67, with time since tamoxifen treatment. D Frequencies of mTom+ and YFP+ cells among lymph node CD4+ T cell subsets, and within CD4+CD44+CD69− T cells in skin and LP. Black lines show the best empirical fitted descriptions of these trajectories (Text S1). Shaded areas indicate the 5-day period over which reporter expression was being induced; data from these periods were not used in the fitting.
During the first few days after tamoxifen treatment, YFP and mTom expression increased continuously within the skin and LP subsets (Fig. 2C), as well as among CD4+ naive (CD44lo CD62Lhi), central memory (TCM, CD44hi CD62Lhi) and effector memory (TEM, CD44hi CD62Llo) T cells recovered from lymph nodes (Fig. 2D). These initial increases were driven in part by the intracellular dynamics of the induction of the fluorescent reporters. We therefore began our analyses at day 5 post-treatment, by which time induction was considered complete and the subsequent trajectories of label frequencies reflected only the dynamic processes of cell production and loss. A key observation was that mTom expression within the skin and LP subsets then declined slowly (roughly 7-to 8-fold over the course of a year, Fig. 2C), indicating immediately that these populations were being continuously replaced from precursors. Early in the chase period YFP+ TRM expressed Ki67 at higher levels than YFP− cells, as expected, but Ki67 expression in the two populations converged at later times. We return to the interpretation of these kinetics below.
We then investigated the extent to which the simple model illustrated in Fig. 1B could explain these trajectories. Given the observation of continued recruitment, any time-variation in the label content of TRM precursors might leave an imprint on the label kinetics of skin or LP TRM themselves, and thereby help us to identify their developmental pathways. We reasoned that plausible TRM precursors might be LN-derived CD4+ naive, TCM or TEM; we also considered the possibilities that CD69− cells within skin and LP are the direct precursors of the local CD69+ populations. Therefore, we used empirical functions to describe the timecourses of the frequencies of YFP+ and mTom+ cells within these five populations (Fig. 2D, black curves), and used them in turn as inputs to the model of YFP and mTom kinetics within the tissues.
For each tissue subset (‘target’) and precursor pair, we fitted the model simultaneously to six timecourses; the frequencies of (i) YFP expression and (ii) mTom expression among target cells, the proportions of Ki67high cells among (iii) YFP+ and (iv) YFP− target cells, and the (v) YFP and (vi) mTom expression kinetics within the precursor (Methods and Supporting Information Text S1). For each precursor/target pair we considered three modes of influx – one in which new immigrant TRM are Ki67low (‘quiescent’ recruitment); another in which their Ki67 expression directly reflects that of the precursor (‘neutral’ recruitment), and a third in which immigrants have recently divided (Ki67high), perhaps through an antigen-driven process (‘division-linked’ recruitment).
Skin and LP CD4+ TRM have similar residence times but exhibit distinct contributions of replacement and self-renewal
For each precursor and mode of recruitment, we were able to estimate rates of influx, residence times and interdivision times (Fig. 3 and Table S1). Overall, we found that the residence times of both EM and TRM within skin and LP were around 3 weeks and 2 weeks respectively. The means of production of new cells differed at the two sites, however. In skin, around 2% of both populations were replaced daily by influx, comparable to the rates of constitutive replacement of circulating memory CD4+ T cell subsets (Gossel et al., 2017, Hogan et al., 2019, Bullock et al., 2024), and self-renewed every 6 and 7 weeks respectively, In contrast, within LP these subsets divided less often (every 7-9 weeks) and relied on higher levels of recruitment (4-6% per day) for their maintenance.

Parameters governing the homeostasis of antigen-experienced CD4+ T cells localised within skin and lamina propria (LP) in adult mice.
Violin plots indicate the posterior distributions of parameters. Black points and bars; best (maximum a posteriori) estimates and 95% credible intervals. For each population (target) in skin or LP, potential precursors were; from lymph nodes, CD4+ naive, central memory and effector memory T cells (N, EM and CM); and for CD4+ TRM, CD69+ TRM within the same tissue. For each precursor/target pair, we considered three potential levels of Ki67 expression on immigrant cells (L-R; orange, red, and blue violin plots). ‘High’, the division-linked model (new cells enter as Ki67high); ‘Int’, neutral model (Ki67 expression among new cells mirrors that of the precursor); and ‘Low’, the quiescent model (new cells enter as Ki67low). Shaded regions highlight the parameter estimates derived from the favoured model (precursor and Ki67 levels on immigration) for each target (Fig. 4A).
From these basic quantities we could derive several other important measures of TRM behaviour. First, the balance of the rates of loss (δ) and self-renewal (ρ) defines the persistence of a cohort of T cells, which is distinct from the lifepan of its constituent cells (del Amo et al., 2018, De Boer and Yates, 2023). Specifically, the quantity ln(2)/(δ− ρ) is the average time taken for a cohort and their descendents to halve in number. While we studied polyclonal populations here, this quantity applies equally well to measuring the persistence of a TCR clonotype, so we refer to it as a clonal half life (Bullock et al., 2024). The substantial rates of self-renewal in skin led to clonal half lives of just over a month. The lower levels of self-renewal and higher levels of replacement in LP resulted in shorter clonal half-lives of 2 weeks.
Importantly, our estimates of these quantities depended to varying degrees on the choice of precursor and mode of recruitment (Fig. 3). For example, intuitively, given the observed level of Ki67 within each target population, the greater the levels of Ki67 within newly recruited cells, the less must derive from self-renewal; hence, if one assumes that recruitment is division-linked, estimated division rates are reduced. Similarly, as discussed above, the label content of the precursor influences the net loss rate of label in the target, which was most clearly reflected in the loss of mTom+ cells over the longer chase period (Fig. 2C and D). For example, mTom was lost most rapidly within naive CD4+ T cells (Fig. 2D), due to export of label-negative cells from the thymus. Models in which naive T cells were the direct precursor of TRM therefore predicted greater clonal persistence within tissues.
We saw very little decline in YFP expression levels during the 2 month chase period (Fig. 2C), due in part to the sustained levels of YFP within the putative precursor populations (Fig. 2D), which ‘topped up’ YFP-expressing TRM. As a result, YFP kinetics within the tissues was not strongly informative regarding rates of replacement. However, the rate of convergence of Ki67 within YFP+ and YFP− cells (Fig. 2C) put clear constraints on the duration of Ki67 expression, which at approximately 3 days (Fig. 3) was consistent with previous estimates. This quantity in turn was informative for estimating rates of self-renewal. Further, the observed convergence of Ki67 within these two subsets is consistent with the basic model assumption of homogeneity in the rates of division and loss within skin and LP.
CD4+ TRM within skin and LP may derive predominantly from effector-memory cells in lymph nodes
To more precisely quantify the kinetics of each target population, we assessed the relative support for each combination of precursor and mode of recruitment (Fig. 4A). Each of these weights summarises the magnitude and uncertainty of a model’s out-of-sample prediction error of the label kinetics within the target population (Methods).

Candidate ontogenic pathways of CD4+ CD69+ TRM in skin and lamina propria.
A For each target population with skin and LP (CD4+ EM bulk, and CD4+CD69+ T cells), we calculated the relative support for alternative pathways and modes of recruitment, using LOO-IC weights (Methods). For potential precursors, N, CM, EM refer to naive, TCM and TEM in lymph nodes, and we also considered CD69− cells within each tissue. As described in the text, for each precursor, there were three potential levels of Ki67 on newly recruited cells. Model weights sum to 1 for each target population, with the width of each arrow reflecting the degree of support. B Schematics of the most strongly supported pathways of development of CD4+CD69+ TRM in skin and LP, with approximate values of key kinetic parameters (Fig. 3 and Table S1).
From the candidate set, the weighting strongly favoured a lymph-node derived EM as the closest precursor to CD4+ EM within both skin and LP. However, within skin, CD69− cells were the favoured precursor to CD69+ TRM. The evidence was more equivocal regarding the mode in which cells are recruited into skin and LP, although for skin we saw substantial evidence (66% of model support) for a division-linked transition from CD69− to CD69+ cells. Fig. 4B summarises the developmental trajectories and kinetics of TRM in skin and LP that were supported most strongly by our analyses. Parameter estimates and credible intervals for these models are highlighted with vertical shaded regions in Fig. 3 and are detailed in Supporting Information, Table S1.
Validation of residence times through use of Ki67 expression directly
As a consistency check, when a population is at or close to steady state, bounds on the mean residence time of cells can be estimated using only the measured frequency of Ki67 within the target population, and the daily rate of replacement (Supporting Information, Text S2). In skin, both EM and TRM are replaced at the rate of 2% per day, and have Ki67 expression frequencies of around 0.15 (Fig. 2C). The approximation then yields residence times in the range 22-28 days, depending on whether immigrant TRM are Ki67low or Ki67high respectively. In LP, with 5.5% daily replacement and Ki67 frequencies of around 0.07, we estimate residence times of 14-25 days. Both estimates are in good agreement with those from the model fitting. Further validation of these results, and dissection of the kinetics, might be achieved my manipulating cell trafficking, although this would potentially impact multiple processes at once. For example, treating mice with the sphingosine 1-phosphate receptor agonist FTY720 would block tissue ingress and egress. This would leave self-renewal as the only means of TRM production, and would also remove the component of the cell loss rate that is due to cells leaving the tissue. In principle one could then gain estimates of the intrinsic lifespan of TRM, rather than their tissue residence time. However, parameter estimation would then require accurate measurements of cell numbers within the tissue.
Discussion
Our analysis indicates that CD4+ TRM are not intrinsically long-lived, but instead are sustained by both self-renewal and supplementation from circulating precursors. By combining fate reporting methods with mathematical models, we also showed that it is possible to separately quantify the processes that underlie their persistence. We saw quite distinct contributions of recruitment and self-renewal of both subsets within skin and LP. The basis of this difference is unclear, but we speculate that the large antigenic burden within the small intestine drives the higher levels of TRM recruitment and clonal erosion within the lamina propria. We showed that the precise values of these quantities depend on the identity of any precursor, whose label kinetics propagate downstream into the population of interest; and the extent of any cell division that occurs around the time of differentiation or ingress. However, by using simple, easily interpretable mathematical models, and assessing the statistical support for each, we were able to identify different pathways and modes of recruitment into each subset.
Our analysis was rooted in the observation of steady-state numbers of CD4+ subsets within these tissues, which dictates that immigration of new cells must be accompanied by loss of existing cells. Estimates of residence times may be quite different if homeostatic niches are flexible in size. For example, repeated vaccinia virus challenges can drive progressive increases in the numbers of virus-specific CD8+ TRM in skin (Jiang et al., 2012), and heterologous challenges appear not to erode pre-existing LCMV-specific CD8+ TRM (Wijeyesinghe et al., 2021). Whether the same principles apply to CD4+ TRM following repeated challenges is unclear.
Our goal here was to assess the support for external replenishment of effector-memory-like CD4+ T cells in bulk, and the dominant CD69+ TRM subset. With richer phenotyping of tissue-localised cells, we could in principle use the labelling trajectories to further dissect these differentiation pathways, in the same way that we saw evidence that CD69+CD4+ TRM in skin may be fed from a local CD69− precursor. One issue is that accurate measurement of label frequencies becomes more difficult as one resolves TRM into finer-grained populations, and indeed we saw that label kinetics within the small CD69− populations were relatively noisy. Another issue is that label kinetics in these reporter mice operate on the timescales of the net loss rate of cell populations – loss balanced by self-renewal. More frequent sampling would be required to resolve more transitory intermediates. Nevertheless, our study shines a light upon the highly dynamic nature of CD4+ TRM, sustained throughout life by both self renewal and continued influx from precursors. The tissue-specific contributions of these processes may contribute to the differential longevity of immunity at different barrier sites.
Methods
Reporter mouse strains
Ki67mCherry-CreERT Rosa26RcagYFP (Ki67-DIVN) and CD4CreERT Rosa26RmTom (Cd4-FR) mice have been described previously (Bullock et al., 2024). Experimental Ki67-DIVN mice were homozygous for indicated mutations at both the Ki67 and Rosa26 loci. Experimental CD4-FR mice were heterozygous for the indicated mutations and both the CD4 and Rosa26 loci. Tamoxifen (Sigma) was diluted to 20mg/mL in corn oil (Fisher Scientific) and 100μl (2mg) was administered to mice via oral feeding on day 0. Ki67-DIVN mice were injected with 2μg Thy1.2-BV510 (53-2.1) (BioLegend) 3 minutes prior to sacrifice to label T cells in the circulation. Mice were subsequently taken down at specified timepoints post tamoxifen treatment for organ collection.
Cell preparation
All peripheral lymph nodes (LN), the small intestine (SI) and ear skin were taken from mice and processed into single cell suspensions. LNs were mashed through 2 pieces of fine gauze in a petri dish and washed with complete RPMI (ThermoFisher) supplemented with 5% FCS (ThermoFisher) (cRPMI). Cells were resuspended in cold PBS and counted using the CASY counter (Cambridge Bioscience). Peyer’s patches were excised from the antimesenteric side of the SI before being opened longitudinally and SI contents scraped out. SI pieces were placed in 20mL pre-warmed extraction media (cRPMI + 10mM HEPES (ThermoFisher) + 5mM EDTA (Sigma) + 1mM DTT (Abcam)) and incubated in 37° C shaking incubator for 30 minutes at 200rpm. Cells were filtered over 70μm cell strainer (supernatant containing intra-epithelial lymphocytes not used), and SI pieces were placed in cold cRPMI supplemented with 10mM HEPES and allowed to settle. Supernatant was carefully poured off and SI pieces were finely minced, added to 20mL pre-warmed digestion media (RPMI + 10% FCS + 1.5mg/mL collagenase VIII (Sigma)) and incubated in 37° C shaking incubator for 30 minutes at 200rpm. After digestion, cells were passed through 70μm cell strainer and washed with cRPMI + 10mM HEPES. The resulting cell suspension contains cells from the lamina propria (LP) of the SI. Ear skin was excised and separated into dorsal and ventral sides. Skin was finely minced, added to 4mL digestion buffer (cRPMI + 50mM HEPES + 37.5μg/mL Liberase TL (Merck)+ 3.125mg/mL collagenase IV (ThermoFisher)+ 1mg/mL DNAse I (Merck)) and incubated in 37° C C shaking incubator for 2 hours at 200rpm. Cells were filtered over 70μm cell strainer and washed through with cRPMI.
Flow cytometry
All cells isolated from skin and LP, and 5 × 106 LN cells, were stained for analysis by flow cytometry. Cells were stained in 100μl PBS with combinations of: CD8α-BUV395 (53-6.7), CD25-BUV395 (PC61), CD62L-BUV737 (MEL-14), TCRγδ-BV421 (GL3), CD103-BV786 (M290) (all BD Biosciences); CD25-BV650 (PC61), CD103-BV421 (2E7), CD8α-BV570 (53-6.7), TCRγδ-BV605 (GL3), NK1.1-BV650 (PK136), CD44-BV785 (IM7), CD45.1-BV605 (A20), CD4-BV711 (RM4-5), CD8b.2-APC (53-5.8) (all BioLegend); TCRβ-PerCPCy5.5 (104) (Cambridge Bioscience); CD44-APCef780 (IM7) (eBioscience); and CD3-APCef780 (2C11), CD3-biotin (145-2C11), CD69-PeCy7 (H1.2F3), CD45.2-AF700 (104), nearIR live/dead, blue live/dead, yellow live/dead (all ThermoFisher). Cells were fixed for 20 minutes with IC fix (Invitrogen) and washed twice in FACS buffer (PBS + 0.1% BSA). Flow cytometric analysis was performed on either a Cytek Aurora spectral flow cytometer or a conventional BD LSR-Fortessa and analysed using FlowJo software (Treestar).
Cell count calculations
Cell counts of LN populations were calculated by dividing the event count in a target population by the event count of live cells, multiplied by the total live cells in LN prep determined by CASY counter. Cell counts of LP and skin populations were calculated using AccuCount (Spherotech) counting beads that were spiked into the sample prior to acquisition, as per manufacturer’s instructions.
Mathematical Modeling and Statistical Analysis
We fitted simultaneously the kinetically homogeneous mathematical model illustrated in Fig. 1B, and described in Supporting Information Text S1, to the time courses of frequencies of YFP+, Ki67high in YFP+, Ki67high in YFP-, and mTom+ cells in the target populations; and empirical descriptor functions describing the trajectories of the frequencies of YFP+ and mTom+ precursors (all data shown in Fig. 2C). We used a Bayesian estimation approach using Python and Stan (Stan Development Team, 2024) to perform these model fits. Code and data used to perform model fitting, details of the prior distributions for parameters, and figure generation notebooks are available at https://github.com/elisebullock/CD4TRM. Models were ranked based on information criteria estimated using the Leave-One-Out (LOO) cross validation method (Vehtari et al., 2017). See Supporting Information, Text S1 for full details.
Acknowledgements
This work was supported by the National Institutes of Health (R01 AI093870 and U01 AI150680) and the Medical Research Council (MR/P011225/1).
Additional files
Note
This reviewed preprint has been updated to correct the author list.
References
- Quantifying thymic export: combining models of naive T cell prolif-eration and TCR excision circle dynamics gives an explicit measure of thymic outputJ Immunol 183:4329–36
- In vivo deuterium labelling in mice supports a dynamic model for memory T-cell maintenance in the bone marrowImmunol Lett 210:29–32
- Short lifespans of memory T-cells in bone marrow, blood, and lymph nodes suggest that T-cell memory is maintained by continuous self-renewal of recirculating cellsFront Immunol 9:2054
- Resident memory CD8 T cells persist for years in human small intestineJ Exp Med 216:2412–2426
- CD4+ T cells persist for years in the human small intestine and display a TH1 cytokine profileMucosal Immunol 14:402–410
- The dynamics and longevity of circulating CD4+ memory T cells depend on cell age and not the chronological age of the hostPLoS Biol 22:e3002380
- Homeostatic turnover of virus-specific memory CD8 T cells occurs stochastically and is independent of CD4 T cell helpJ Immunol 185:3436–44
- Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticityNat Immunol 22:1140–1151
- Quantifying T lymphocyte turnoverJ Theor Biol 327:45–87
- Modeling T Cell FateAnnu Rev Immunol 41:513–532
- Human TSCM cell dynamics in vivo are compatible with long-lived immunological memory and stemnessPLoS Biology 16:1–22
- Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humansImmunity 36:288–97
- Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host diseaseJ Clin Invest 130:4624–4636
- Memory T cell populations in the lung airways are maintained by continual recruitmentJ Immunol 176:537–543
- Common clonal origin of central and resident memory T cells following skin immunizationNature Medicine 21:647–653
- A mechanistic model for bromodeoxyuridine dilution naturally explains labelling data of self-renewing T cell populationsJ R Soc Interface 10:20120617
- Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virusNat Immunol 10:524–30
- Memory CD4 T cell subsets are kinetically heterogeneous and replenished from naive T cells at high levelseLife 6:e23013
- Differential impact of self and environmental antigens on the ontogeny and maintenance of CD4+ T cell memoryeLife 8:e48901
- Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunityNature 483:227–231
- Quantifying cellular dynamics in mice using a novel fluorescent division reporter systemFront Immunol 14:1157705
- Central memory T cells are the most effective precursors of resident memory T cells in human skinSci Immunol 7:eabn1889
- Ki67 is a graded rather than a binary marker of proliferation versus quiescenceCell Rep 24:1105–1112
- Tissue-Resident Memory T Cells in Mice and Humans: Towards a Quantitative EcologyJ Immunol 203:2561–2569
- Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses articleNature Immunology 19:183–191
- Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunitySci Immunol 2:eaag2031
- Stan Modeling Language Users Guide and Reference Manual, version 2.34
- Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host diseaseSci Transl Med 12:eabb7028
- Location, location, location: Tissue resident memory T cells in mice and humansSci Immunol 4
- Establishment and maintenance of conventional and circulation-driven lungresident memory CD8+ T cells following respiratory virus infectionsFront Immunol 10:733
- Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenanceJ Exp Med 213:3057–3073
- Repeated antigen exposure extends the durability of influenza-specific lung-resident memory CD8+ T cells and heterosubtypic immunityCell Reports 24:3374–3382
- Quantification of T-cell dynamics during latent cytomegalovirus infection in humansPLoS Pathog 17:e1010152
- A variational deep-learning approach to modeling memory T cell dynamicsbioRxiv https://doi.org/10.1101/2024.07.08.602409
- Practical Bayesian model evaluation using leave-one-out cross-validation and WAICStat Comput 27:1413–1432
- Fate mapping quantifies the dynamics of B cell development and activation throughout lifeCell Reports 33:108376
- Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cellsScience Translational Medicine 7
- Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humansBlood 122:2205–12
- Lymphocyte maintenance during healthy aging requires no substantial alterations in cellular turnoverAging Cell 14:219–27
- Expansible residence decentralizes immune homeostasisNature 592:457–462
- Memory phenotype CD4 T cells undergoing rapid, nonburst-like, cytokine-driven proliferation can be distinguished from antigen-experienced memory cellsPLoS Biol 9:e1001171
- Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migrationImmunity 24:439–449
Article and author information
Author information
Version history
- Sent for peer review:
- Preprint posted:
- Reviewed Preprint version 1:
Copyright
© 2025, Chandler et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
- views
- 52
- downloads
- 0
- citations
- 0
Views, downloads and citations are aggregated across all versions of this paper published by eLife.